Breast Cancer Research

official impact factor 5.79

This article is part of the supplement: Breast Cancer Research 2008

Development of breast cancer immunotherapy using MUC1-retargeted T lymphocytes

S Wilkie, G Picco, J Foster, D Davies, S Julien, L Cooper, S Arif, S Mather, J Taylor-Papadimitriou, J Burchell and J Maher

Breast Cancer Research 2008, 10(Suppl 2):O6 doi:10.1186/bcr1881

Accesses  

  • Last 30 days: 32 accesses
  • Last 365 days: 263 accesses
  • All time: 1362 accesses